These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 23369094)
1. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Md S; Ali M; Baboota S; Sahni JK; Bhatnagar A; Ali J Drug Dev Ind Pharm; 2014 Feb; 40(2):278-87. PubMed ID: 23369094 [TBL] [Abstract][Full Text] [Related]
2. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers. Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595 [TBL] [Abstract][Full Text] [Related]
3. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies. Patil GB; Surana SJ J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812 [TBL] [Abstract][Full Text] [Related]
4. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral. Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Seju U; Kumar A; Sawant KK Acta Biomater; 2011 Dec; 7(12):4169-76. PubMed ID: 21839863 [TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting. Mistry NP; Desai JL; Thakkar HP J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126 [TBL] [Abstract][Full Text] [Related]
7. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A. Jose S; Sowmya S; Cinu TA; Aleykutty NA; Thomas S; Souto EB Eur J Pharm Sci; 2014 Oct; 63():29-35. PubMed ID: 25010261 [TBL] [Abstract][Full Text] [Related]
8. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery. Yuan Z; Gu X Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633 [TBL] [Abstract][Full Text] [Related]
10. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies. Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818 [TBL] [Abstract][Full Text] [Related]
11. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release]. Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627 [TBL] [Abstract][Full Text] [Related]
12. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Joshi SA; Chavhan SS; Sawant KK Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869 [TBL] [Abstract][Full Text] [Related]
13. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency. Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112 [TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG)-loaded poly(lactic acid-co-glycolic acid) nanoparticles. Pradhan R; Poudel BK; Choi JY; Choi IS; Shin BS; Choi HG; Yong CS; Kim JO Arch Pharm Res; 2015; 38(5):734-41. PubMed ID: 24824337 [TBL] [Abstract][Full Text] [Related]
15. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations. Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548 [TBL] [Abstract][Full Text] [Related]
16. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies. Lalani J; Rathi M; Lalan M; Misra A Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442 [TBL] [Abstract][Full Text] [Related]
17. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Mukerjee A; Vishwanatha JK Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921 [TBL] [Abstract][Full Text] [Related]
18. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
19. Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro. Baysal I; Ucar G; Gultekinoglu M; Ulubayram K; Yabanoglu-Ciftci S J Neural Transm (Vienna); 2017 Jan; 124(1):33-45. PubMed ID: 26911385 [TBL] [Abstract][Full Text] [Related]
20. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats. Simon LC; Sabliov CM Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]